MAPK1 and cholangiocarcinoma: The GSVA based on proteomic and phosphoproteomic data suggested that the ERK phosphorylation, MAPK activity, and antigen processing and presentation (APCs) were overrepresented in patients with CCA‐HBV (Figure 5C; Table S5).